Dr. Simpkins is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3400 Civic Center Blvd
# B
Philadelphia, PA 19104Phone+1 215-662-3318Fax+1 215-349-5849
Summary
- Dr. Fiona Simpkins is an obstetrician/gynecologist in Philadelphia, PA and is affiliated with multiple hospitals in the area, including Hospital of the University of Pennsylvania and Pennsylvania Hospital. She received her medical degree from Lewis Katz School of Medicine at Temple University and has been in practice 18 years. She specializes in gynecologic oncology and is experienced in fallopian tube carcinoma, gynecologic oncology, and cervical cancer. She has more than 50 publications and over 500 citings.
Education & Training
Johns Hopkins UniversityResidency, Obstetrics and Gynecology, 1999 - 2003
Lewis Katz School of Medicine at Temple UniversityClass of 1999
Cleveland Clinic FoundationFellowship, Gynecologic Oncology
Certifications & Licensure
FL State Medical License 2008 - 2024
PA State Medical License 2013 - 2024
OH State Medical License 2005 - 2010
MD State Medical License 2003 - 2009- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Clinical Trials
- Combination ATR and PARP Inhibitor (CAPRI) Trial With AZD6738 and Olaparib in Recurrent Ovarian Cancer Start of enrollment: 2018 Mar 09
Publications & Presentations
PubMed
- 31 citationsAn autologous humanized patient-derived-xenograft platform to evaluate immunotherapy in ovarian cancerSarah B. Gitto, Hyoung Kim, Stavros Rafail, Dalia K. Omran, Sergey Medvedev
Gynecologic Oncology. 2020-01-01 - 9 citationsA Phase Ib Study Assessing the Safety, Tolerability, and Efficacy of the First-in-Class Wee1 Inhibitor Adavosertib (AZD1775) as Monotherapy in Patients with Advanced S...Todd M Bauer, Kathleen N Moore, Janet S Rader, Fiona Simpkins, Alain C Mita
Targeted Oncology. 2023-07-01 - 180 citationsCombining PARP with ATR inhibition overcomes PARP inhibitor and platinum resistance in ovarian cancer modelsHyoung Kim, Haineng Xu, Erin George, Dorothy Hallberg, Sushil Kumar
Nature Communications. 2020-07-24
Journal Articles
- Dual Src and MEK Inhibition Decreases Ovarian Cancer Growth and Targets Tumor Initiating Stem-like CellsFiona Simpkins, MD, Clinical Cancer Research
Press Mentions
Penn Medicine at the AACR Annual Meeting 2023April 7th, 2023
Analysis Reveals Genomic Effects of a New Cancer Treatment Now in Clinical TrialsOctober 3rd, 2018
PARP-1 May Be Key to Effectiveness of PARP Inhibitors, and Now Researchers Can Image ItApril 27th, 2018- Join now to see all
Professional Memberships
- Fellow
Other Languages
- French
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
